DSM-Firmenich Adjusted EBITDA Rises 8% Year Over Year in Q3
DSM-Firmenich reported adjusted EBITDA up 8% year over year on a comparable basis in the third quarter of 2026.
Story updates
06:03:45 AM UTC
SquawkNews
DSM-Firmenich Q3 2026 adjusted EBITDA rises 8% year on year on LFL basis to €482 million DSM-Fir